GSK’s Tres Cantos Medicines Development Campus

Showing 1 posts of 1 posts found.

GSK partners with Brazil’s Fiocruz on tropical disease research

November 15, 2010
Research and Development Chagas disease, Fiocruz, GSK, GSK’s Tres Cantos Medicines Development Campus, GlaxoSmithKline, Oswald Cruz Foundation, leishmaniasis

GlaxoSmithKline and the Brazil-based Oswald Cruz Foundation (Fiocruz) are to research and develop new medicines for tropical diseases Chagas and …

The Gateway to Local Adoption Series

Latest content